about
The promise of neuroprotective agents in Parkinson's diseaseAlpha-tocopherol protects against oxidative stress in the fragile X knockout mouse: an experimental therapeutic approach for the Fmr1 deficiency.Feeding of Nigella sativa during neonatal and juvenile growth improves learning and memory of rats.Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease.A systematic review of nutritional risk factors of Parkinson's disease.Ingredient Consistency of Commercially Available Polyphenol and Tocopherol Nutraceuticals.α-Tocopherol incorporation in mitochondria and microsomes upon supranutritional vitamin E supplementationMitochondrial dysfunction in psychiatric and neurological diseases: cause(s), consequence(s), and implications of antioxidant therapy.The centrality of mitochondria in the pathogenesis and treatment of Parkinson's disease.ATPase activity of p97/valosin-containing protein is regulated by oxidative modification of the evolutionally conserved cysteine 522 residue in Walker A motif.Rice Bran Dietary Supplementation Improves Neurological Symptoms and Loss of Purkinje Cells in Vitamin E-Deficient Mice.Protective Effects of Vitamin E Consumption against 3MT Electromagnetic Field Effects on Oxidative Parameters in Substantia Nigra in Rats.Beneficial Effect of Vitamin E in Rotenone Induced Model of PD: Behavioural, Neurochemical and Biochemical Study.The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease.Oxidative stress and serum paraoxonase activity in experimental hypothyroidism: effect of vitamin E supplementation.Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.Analogues of desferrioxamine B designed to attenuate iron-mediated neurodegeneration: synthesis, characterisation and activity in the MPTP-mouse model of Parkinson's disease.Feeding Vitamin C during Neonatal and Juvenile Growth Improves Learning and Memory of Rats.Vitamin E protected cultured cortical neurons from oxidative stress-induced cell death through the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase.N-acetylcysteine and vitamin E rescue animal longevity and cellular oxidative stress in pre-clinical models of mitochondrial complex I disease.
P2860
Q21129436-8D347EED-D5C8-44EA-8B70-25C134111308Q34848818-CC688B47-96E8-4FC8-9C95-E16D865D1FF2Q36803079-07C6EFC9-57FC-4F7A-9F5B-EE5ABAAB3A88Q36968109-54996D68-1178-488B-9C43-78557F937870Q37350053-B910BD8A-F5CE-4F07-88D8-57DD3EA4E427Q37669981-343E9925-6458-4D84-8BA5-18FD0A23F345Q37987048-2FF0DD2F-E735-4EC2-BF45-E905AE0D1092Q38086474-DA484903-7802-40C4-9619-E399D8557AD9Q38202314-51C307B7-6731-442B-BA90-E67BA4233E36Q40360531-CE951B2F-5FBB-42A9-817C-FF520F4FEE68Q41319995-6E2CFA66-C9FF-44EA-A55E-CBFDD4203970Q41764686-E4C3E610-7D6B-4B52-9635-7328BB85B237Q41884130-1DD2B90A-E8FE-473E-A99D-5F0CFBFEE34DQ42116736-63D70448-51AA-43B4-B624-94AD30BDBE7CQ45073574-966B0CA2-81C6-4690-8371-4BDEB531C435Q45124967-49831030-8953-4854-A5F1-306657782EF7Q46372704-4C096C4C-7287-46A0-BD46-E24A7CE0E743Q47782423-4CFCF2C5-8968-45FD-B81B-3597F55E14D2Q48547079-C688DE32-353A-48AB-B1E9-C735C4C3F337Q52360003-F51A7131-7B18-4A5B-84FE-A8CB3078BC6A
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Vitamin E therapy in Parkinson's disease.
@ast
Vitamin E therapy in Parkinson's disease.
@en
type
label
Vitamin E therapy in Parkinson's disease.
@ast
Vitamin E therapy in Parkinson's disease.
@en
prefLabel
Vitamin E therapy in Parkinson's disease.
@ast
Vitamin E therapy in Parkinson's disease.
@en
P1433
P1476
Vitamin E therapy in Parkinson's disease.
@en
P2093
Jin-Gang Zhang
Marc W Fariss
P304
P356
10.1016/S0300-483X(03)00158-6
P407
P577
2003-07-01T00:00:00Z